And the beat goes onis a refrain that kept rolling through my head after attending the symposium Tuesday hosted by the Womens Institute for a Secure Retirement (WISER) in Washington, D.C. The topic: retirement solutions for women.
When the S&P 500 hit a new all-time high on Monday, investors on the sideline were left with a choice worthy of Hamlet: To buy or not to buy? FBN’s JC OHara urges patience:
With the uptick in new bottom up highs as well as a new overall high for the S&P 500, can we be safe to assume the Bulls are back in charge? Well, we remain comfortable neutral for the time being....More>>>
A decent start for stocks on Wednesday quickly turned into red-alert session, with the selling prompted by nothing in particular … nothing other than a disinterest in buyers. The 0.84% tumble the S&P 500 took today left it at 2,249.92, hovering just a hair above a key technical support level.
Leading the bearish charge were Fitbit Inc (NYSE:FIT), Twilio Inc (NYSE:TWLO) and Nvidia....More>>>
Organovo Holdings Inc. (NASDAQ: ONVO) shares saw a handy gain on Tuesday after the bio-printer announced that it received a strong consumer response from its second tissue service. Specifically, the ExVive Human Kidney Tissue launched in September, which uses Organovos 3D bio-printed kidney tissue to study the effects of drug exposure through toxicology panels and transporter studies.
The consumer products industry is bracing for another year of sluggish global growth and brutal competition. Those dynamics mean that Procter & Gamble (NYSE:PG), despite its improved portfolio and lower cost structure, might again post disappointing operating results. It is targeting 2% organic sales gains in 2017, which would mark an improvement over the prior year, but still implies a third....More>>>
Teck Resources (NYSE:TECK) performed exceptionally well in 2016, rising from the low single digits to the mid-$20s. I don’t think the stock will repeat that strong performance in 2017. However, I do think the stock will outperform the S&P 500 with strong double-digit gains. Teck Resources’ recent 20% pullback has the stock at an oversold level. The stock remains undervalued as compared....More>>>
On Friday, small cap biotechArrowhead Pharmaceuticals (NASDAQ: ARWR) jumped 18.28% after hosting an investor & analyst R&D day to introduce its proprietary Targeted RNAi Molecule (TRiMTM) platform and to review its pipeline of RNAi therapeutic candidates. Arrowhead Pharmaceuticals develop